Since writing this article, this is actually one of the things I’ve been looking into! I think it looks very promising, as many of the issues outlined by WHO seem downstream from people simply being unable to afford high quality antivenom. (ie. why do people choose local healers? Because hospitals cost more and don’t help either!)
It also looks like the marginal cost of high quality antivenom would decrease up to an order of magnitude if you scale up production. I have yet to take an in depth look at synthetic antivenom production, but after briefly looking into it, it seems that we are not going to get synthetic antivenom just yet.
Since writing this article, this is actually one of the things I’ve been looking into! I think it looks very promising, as many of the issues outlined by WHO seem downstream from people simply being unable to afford high quality antivenom. (ie. why do people choose local healers? Because hospitals cost more and don’t help either!)
It also looks like the marginal cost of high quality antivenom would decrease up to an order of magnitude if you scale up production. I have yet to take an in depth look at synthetic antivenom production, but after briefly looking into it, it seems that we are not going to get synthetic antivenom just yet.